Loading company details...
Beta
Latest Form 4 (Sep 15, 2026): Jude Onyia (Chief Scientific Officer): Grant/Award of 3,587 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Jude Onyia, Chief Scientific Officer | Grant/Award | 3,587 | n/a |
| Sep 15, 2026 | Darin Lippoldt, Chief Legal Officer | Grant/Award | 4,483 | n/a |
| Sep 15, 2026 | Sanjay Chandru Keswani, Chief Medical Officer | Grant/Award | 3,914 | n/a |
| Sep 15, 2026 | Kevin Charles Gorman | Grant/Award | 14,343 | n/a |
| Sep 15, 2026 | Kyle Gano, Chief Executive Officer | Grant/Award | 6,275 | n/a |
| Sep 15, 2026 | Ingrid Delaet, Chief Regulatory Officer | Grant/Award | 4,483 | n/a |
| Sep 15, 2026 | Julie Cooke, Chief Human Resources Officer | Grant/Award | 3,587 | n/a |
| Sep 15, 2026 | David W. Boyer, Chief Corp. Affairs Officer | Grant/Award | 3,587 | n/a |
| Sep 15, 2026 | Eric Benevich, Chief Commercial Officer | Grant/Award | 6,275 | n/a |
| Sep 15, 2026 | Matt Abernethy, Chief Financial Officer | Grant/Award | 5,020 | n/a |